BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/22/2026 6:00:36 AM | Browse: 2 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Salih Karatlı, Doğan Yazılıtaş, Seher Kaya, Gökşen İ İmamoğlu, Selahattin Çelik and Galip C Uyar |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salih Karatlı, MD, Department of Medical Oncology, Ankara Etlik City Hospital, Varlık Neighborhood, Halil Sezai Erkut Avenue, Yenimahalle, Ankara 06000, Türkiye. karatlisalih@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Pan-immune-inflammation value; Systemic inflammation; Prognostic biomarkers; Albumin-bilirubin score; Model for end-stage liver disease-sodium score; Survival; Prognosis |
| Core Tip |
Pan-immune-inflammation value (PIV) is a novel biomarker reflecting systemic inflammatory and immune status in hepatocellular carcinoma (HCC). In this retrospective study, PIV demonstrated superior prognostic performance compared with conventional liver function scores such as albumin-bilirubin and model for end-stage liver disease-sodium and remained an independent predictor of overall survival. These findings suggest that inflammation-based indices may improve risk stratification beyond traditional liver function-based models in patients with HCC. |
| Citation |
Karatlı S, Yazılıtaş D, Kaya S, İmamoğlu Gİ, Çelik S, Uyar GC. Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium. World J Gastrointest Oncol 2026; In press |
 |
Received |
|
2026-03-19 00:41 |
 |
Peer-Review Started |
|
2026-03-19 00:42 |
 |
First Decision by Editorial Office Director |
|
2026-04-04 02:12 |
 |
Return for Revision |
|
2026-04-04 02:12 |
 |
Revised |
|
2026-04-08 00:25 |
 |
Publication Fee Transferred |
|
2026-04-14 13:39 |
 |
Second Decision by Editor |
|
2026-04-22 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-22 06:00 |
 |
Articles in Press |
|
2026-04-22 06:00 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345